;PMID: 10811128
;source_file_2946.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:43..119] = [t:43..119]
;2)section:[e:123..167] = [t:123..167]
;3)section:[e:171..272] = [t:171..272]
;4)sentence:[e:276..433] = [t:276..433]
;5)sentence:[e:435..547] = [t:435..547]
;6)sentence:[e:548..631] = [t:548..631]
;7)sentence:[e:632..752] = [t:632..752]
;8)sentence:[e:753..1013] = [t:753..1013]
;9)sentence:[e:1014..1158] = [t:1014..1158]
;10)sentence:[e:1159..1460] = [t:1159..1460]
;11)section:[e:1464..1509] = [t:1464..1509]

;section 0 Span:0..37
;Cancer Res.  2000 May 1;60(9):2483-7.
(SEC
  (FRAG (NNP:[0..6] Cancer) (NNP:[7..10] Res) (.:[10..11] .) (CD:[13..17] 2000)
        (NNP:[18..21] May) (CD:[22..26] 1;60) (-LRB-:[26..27] -LRB-)
        (CD:[27..28] 9) (-RRB-:[28..29] -RRB-) (CD:[29..34] :2483)
        (::[34..35] -) (CD:[35..37] 7.)))

;sentence 1 Span:43..119
;Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
;[66..83]:variation-type:"allelic imbalance"
;[105..118]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP
      (ADJP (NN:[43..49] Genome) (HYPH:[49..50] -) (JJ:[50..54] wide))
      (NN:[55..61] screen))
    (PP (IN:[62..65] for)
      (NP (JJ:[66..73] allelic) (NN:[74..83] imbalance)))
    (PP (IN:[84..86] in)
      (NP (DT:[87..88] a) (NN:[89..94] mouse) (NN:[95..100] model)))
    (PP (IN:[101..104] for)
      (NP (NN:[105..118] neuroblastoma)))
    (.:[118..119] .)))

;section 2 Span:123..167
;Weiss WA, Godfrey T, Francisco C, Bishop JM.
(SEC
  (FRAG (NNP:[123..128] Weiss) (NNP:[129..131] WA) (,:[131..132] ,)
        (NNP:[133..140] Godfrey) (NNP:[141..142] T) (,:[142..143] ,)
        (NNP:[144..153] Francisco) (NNP:[154..155] C) (,:[155..156] ,)
        (NNP:[157..163] Bishop) (NNP:[164..166] JM) (.:[166..167] .)))

;section 3 Span:171..272
;Department of Neurology, University of California, San Francisco 94143-0114, 
;USA. weiss@cgl.ucsf.edu
(SEC
  (FRAG (NNP:[171..181] Department) (IN:[182..184] of)
        (NNP:[185..194] Neurology) (,:[194..195] ,) (NNP:[196..206] University)
        (IN:[207..209] of) (NNP:[210..220] California) (,:[220..221] ,)
        (NNP:[222..225] San) (NNP:[226..235] Francisco) (IN:[236..241] 94143)
        (CD:[241..246] -0114) (,:[246..247] ,) (NNP:[249..252] USA)
        (.:[252..253] .) ('':[254..263] weiss@cgl) (.:[263..272] .ucsf.edu)))

;sentence 4 Span:276..433
;We have used the rat tyrosine hydroxylase promotor to overexpress MYCN in the
; neural crest of transgenic mice, resulting in a mouse model for
;neuroblastoma.
;[297..317]:gene-rna:"tyrosine hydroxylase"
;[342..346]:gene-rna:"MYCN"
;[419..432]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (PRP:[276..278] We))
    (VP (VBP:[279..283] have)
      (VP (VBN:[284..288] used)
        (NP (DT:[289..292] the) (NN:[293..296] rat)
           (NN:[297..305] tyrosine) (NN:[306..317] hydroxylase)
          (NN:[318..326] promotor))
        (S-PRP
          (NP-SBJ (-NONE-:[326..326] *))
          (VP (TO:[327..329] to)
            (VP (VB:[330..341] overexpress)
              (NP (NN:[342..346] MYCN))
              (PP (IN:[347..349] in)
                (NP
                  (NP (DT:[350..353] the) (JJ:[355..361] neural)
                      (NN:[362..367] crest))
                  (PP (IN:[368..370] of)
                    (NP (JJ:[371..381] transgenic) (NNS:[382..386] mice)))))
              (,:[386..387] ,)
              (S-ADV
                (NP-SBJ (-NONE-:[387..387] *))
                (VP (VBG:[388..397] resulting)
                  (PP-CLR (IN:[398..400] in)
                    (NP
                      (NP (DT:[401..402] a) (NN:[403..408] mouse)
                          (NN:[409..414] model))
                      (PP (IN:[415..418] for)
                        (NP (NN:[419..432] neuroblastoma))))))))))))
    (.:[432..433] .)))

;sentence 5 Span:435..547
;Using PCR analysis of microsatellite markers, we conducted a genome-wide 
;analysis in tumors from these animals.
(SENT
  (S
    (S-MNR
      (NP-SBJ (-NONE-:[435..435] *))
      (VP (VBG:[435..440] Using)
        (NP
          (NP (NN:[441..444] PCR) (NN:[445..453] analysis))
          (PP (IN:[454..456] of)
            (NP (NN:[457..471] microsatellite) (NNS:[472..479] markers))))))
    (,:[479..480] ,)
    (NP-SBJ (PRP:[481..483] we))
    (VP (VBD:[484..493] conducted)
      (NP (DT:[494..495] a)
        (ADJP (NN:[496..502] genome) (HYPH:[502..503] -) (JJ:[503..507] wide))
        (NN:[509..517] analysis))
      (PP-LOC (IN:[518..520] in)
        (NP
          (NP (NNS:[521..527] tumors))
          (PP (IN:[528..532] from)
            (NP (DT:[533..538] these) (NNS:[539..546] animals))))))
    (.:[546..547] .)))

;sentence 6 Span:548..631
;Regions of chromosomes 1, 3, 10, 11, 14,  and 18 were affected in 20-50% of
;tumors.
;[559..572]:variation-location:"chromosomes 1"
;[559..570]...[594..596]:variation-location:"chromosomes"..."18"
;[559..570]...[585..587]:variation-location:"chromosomes"..."14"
;[559..570]...[581..583]:variation-location:"chromosomes"..."11"
;[559..570]...[577..579]:variation-location:"chromosomes"..."10"
;[559..570]...[574..575]:variation-location:"chromosomes"..."3"
(SENT
  (S
    (NP-SBJ-2
      (NP (NNS:[548..555] Regions))
      (PP (IN:[556..558] of)
        (NP
          (NP
            (NML-1 (NNS:[559..570] chromosomes))
            (CD:[571..572] 1))
          (,:[572..573] ,)
          (NP
            (NML-1 (-NONE-:[573..573] *P*))
            (CD:[574..575] 3))
          (,:[575..576] ,)
          (NP
            (NML-1 (-NONE-:[576..576] *P*))
            (CD:[577..579] 10))
          (,:[579..580] ,)
          (NP
            (NML-1 (-NONE-:[580..580] *P*))
            (CD:[581..583] 11))
          (,:[583..584] ,)
          (NP
            (NML-1 (-NONE-:[584..584] *P*))
            (CD:[585..587] 14))
          (,:[587..588] ,) (CC:[590..593] and)
          (NP
            (NML-1 (-NONE-:[593..593] *P*))
            (CD:[594..596] 18)))))
    (VP (VBD:[597..601] were)
      (VP (VBN:[602..610] affected)
        (NP-2 (-NONE-:[610..610] *))
        (PP (IN:[611..613] in)
          (NP
            (NP
              (QP (CD:[614..616] 20) (HYPH:[616..617] -) (CD:[617..619] 50))
              (NN:[619..620] %))
            (PP (IN:[621..623] of)
              (NP (NNS:[624..630] tumors)))))))
    (.:[630..631] .)))

;sentence 7 Span:632..752
;Analysis of a subset of these tumors  by comparative genomic hybridization
;was consistent with the microsatellite  data.
(SENT
  (S
    (NP-SBJ
      (NP (NN:[632..640] Analysis))
      (PP (IN:[641..643] of)
        (NP
          (NP (DT:[644..645] a) (NN:[646..652] subset))
          (PP (IN:[653..655] of)
            (NP (DT:[656..661] these) (NNS:[662..668] tumors)))))
      (PP (IN:[670..672] by)
        (NP (JJ:[673..684] comparative) (JJ:[685..692] genomic)
            (NN:[693..706] hybridization))))
    (VP (VBD:[707..710] was)
      (ADJP-PRD (JJ:[711..721] consistent)
        (PP (IN:[722..726] with)
          (NP (DT:[727..730] the) (NN:[731..745] microsatellite)
              (NNS:[747..751] data)))))
    (.:[751..752] .)))

;sentence 8 Span:753..1013
;The changes on mouse chromosomes 1, 11, 14, and 18 were syntenic with 
;corresponding regions of loss of heterozygosity in human neuroblastoma, 
;suggesting that genes implicated in the mouse tumors may also play a role in
;the  pathogenesis of the human disease.
;[774..787]:variation-location:"chromosomes 1"
;[774..785]...[801..803]:variation-location:"chromosomes"..."18"
;[774..785]...[793..795]:variation-location:"chromosomes"..."14"
;[774..785]...[789..791]:variation-location:"chromosomes"..."11"
;[849..871]:variation-type:"loss of heterozygosity"
;[881..894]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[753..756] The) (NNS:[757..764] changes))
      (PP (IN:[765..767] on)
        (NP
          (NP
            (NML-1 (NN:[768..773] mouse))
            
            (NML-2 (NNS:[774..785] chromosomes))
            (CD:[786..787] 1))
          (,:[787..788] ,)
          (NP
            (NML-1 (-NONE-:[788..788] *P*))
            (NML-2 (-NONE-:[788..788] *P*))
            (CD:[789..791] 11))
          (,:[791..792] ,)
          (NP
            (NML-1 (-NONE-:[792..792] *P*))
            (NML-2 (-NONE-:[792..792] *P*))
            (CD:[793..795] 14))
          (,:[795..796] ,) (CC:[797..800] and)
          (NP
            (NML-1 (-NONE-:[800..800] *P*))
            (NML-2 (-NONE-:[800..800] *P*))
            (CD:[801..803] 18)))))
    (VP (VBD:[804..808] were)
      (ADJP-PRD (JJ:[809..817] syntenic)
        (PP (IN:[818..822] with)
          (NP
            (NP (VBG:[824..837] corresponding) (NNS:[838..845] regions))
            (PP (IN:[846..848] of)
              (NP
                (NP (NN:[849..853] loss))
                (PP (IN:[854..856] of)
                  (NP (NN:[857..871] heterozygosity))))))))
      (PP (IN:[872..874] in)
        (NP (JJ:[875..880] human) (NN:[881..894] neuroblastoma)))
      (,:[894..895] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[895..895] *))
        (VP (VBG:[897..907] suggesting)
          (SBAR (IN:[908..912] that)
            (S
              (NP-SBJ
                (NP (NNS:[913..918] genes))
                (VP (VBN:[919..929] implicated)
                  (NP (-NONE-:[929..929] *))
                  (PP (IN:[930..932] in)
                    (NP (DT:[933..936] the) (NN:[937..942] mouse)
                        (NNS:[943..949] tumors)))))
              (VP (MD:[950..953] may)
                (ADVP (RB:[954..958] also))
                (VP (VB:[959..963] play)
                  (NP (DT:[964..965] a) (NN:[966..970] role))
                  (PP (IN:[971..973] in)
                    (NP
                      (NP (DT:[974..977] the) (NN:[979..991] pathogenesis))
                      (PP (IN:[992..994] of)
                        (NP (DT:[995..998] the) (JJ:[999..1004] human)
                            (NN:[1005..1012] disease))))))))))))
    (.:[1012..1013] .)))

;sentence 9 Span:1014..1158
;One-third of the mouse tumors shared  abnormalities on chromosomes 1, 3, and
;10, whereas the remainder of tumors did  not show this combination.
;[1069..1082]:variation-location:"chromosomes 1"
;[1069..1080]...[1091..1093]:variation-location:"chromosomes"..."10"
;[1069..1080]...[1084..1085]:variation-location:"chromosomes"..."3"
(SENT
  (S
    (NP-SBJ
      (NP (CD:[1014..1017] One) (HYPH:[1017..1018] -) (NN:[1018..1023] third))
      (PP (IN:[1024..1026] of)
        (NP (DT:[1027..1030] the) (NN:[1031..1036] mouse)
            (NNS:[1037..1043] tumors))))
    (VP (VBD:[1044..1050] shared)
      (NP (NNS:[1052..1065] abnormalities))
      (PP (IN:[1066..1068] on)
        (NP
          (NP
            (NML-1 (NNS:[1069..1080] chromosomes))
            (CD:[1081..1082] 1))
          (,:[1082..1083] ,)
          (NP
            (NML-1 (-NONE-:[1083..1083] *P*))
            (CD:[1084..1085] 3))
          (,:[1085..1086] ,) (CC:[1087..1090] and)
          (NP
            (NML-1 (-NONE-:[1090..1090] *P*))
            (CD:[1091..1093] 10))))
      (,:[1093..1094] ,)
      (SBAR-ADV (IN:[1095..1102] whereas)
        (S
          (NP-SBJ
            (NP (DT:[1103..1106] the) (NN:[1107..1116] remainder))
            (PP (IN:[1117..1119] of)
              (NP (NNS:[1120..1126] tumors))))
          (VP (VBD:[1127..1130] did) (RB:[1132..1135] not)
            (VP (VB:[1136..1140] show)
              (NP (DT:[1141..1145] this) (NN:[1146..1157] combination)))))))
    (.:[1157..1158] .)))

;sentence 10 Span:1159..1460
;These data suggest that genetic mutations on  chromosomes 1, 3, and 10
;cooperate in the pathogenesis of neuroblastoma and that  neuroblastoma in the
;mouse arises from at least two distinct genetic pathways,  one of which is
;dependent on lesions in chromosomes 1, 3, and 10, the other of  which is
;not.
;[1191..1200]:variation-event:"mutations"
;[1205..1218]:variation-location:"chromosomes 1"
;[1205..1216]...[1227..1229]:variation-location:"chromosomes"..."10"
;[1205..1216]...[1220..1221]:variation-location:"chromosomes"..."3"
;[1263..1276]:malignancy-type:"neuroblastoma"
;[1287..1300]:malignancy-type:"neuroblastoma"
;[1396..1403]:variation-event:"lesions"
;[1407..1420]:variation-location:"chromosomes 1"
;[1407..1418]...[1429..1431]:variation-location:"chromosomes"..."10"
;[1407..1418]...[1422..1423]:variation-location:"chromosomes"..."3"
(SENT
  (S
    (NP-SBJ (DT:[1159..1164] These) (NNS:[1165..1169] data))
    (VP (VBP:[1170..1177] suggest)
      (SBAR
        (SBAR (IN:[1178..1182] that)
          (S
            (NP-SBJ
              (NP (JJ:[1183..1190] genetic) (NNS:[1191..1200] mutations))
              (PP-LOC (IN:[1201..1203] on)
                (NP
                  (NP
                    (NML-1 (NNS:[1205..1216] chromosomes))
                    (CD:[1217..1218] 1))
                  (,:[1218..1219] ,)
                  (NP
                    (NML-1 (-NONE-:[1219..1219] *P*))
                    (CD:[1220..1221] 3))
                  (,:[1221..1222] ,) (CC:[1223..1226] and)
                  (NP
                    (NML-1 (-NONE-:[1226..1226] *P*))
                    (CD:[1227..1229] 10)))))
            (VP (VBP:[1230..1239] cooperate)
              (PP (IN:[1240..1242] in)
                (NP
                  (NP (DT:[1243..1246] the) (NN:[1247..1259] pathogenesis))
                  (PP (IN:[1260..1262] of)
                    (NP (NN:[1263..1276] neuroblastoma))))))))
        (CC:[1277..1280] and)
        (SBAR (IN:[1281..1285] that)
          (S
            (NP-SBJ
              (NP (NN:[1287..1300] neuroblastoma))
              (PP (IN:[1301..1303] in)
                (NP (DT:[1304..1307] the) (NN:[1308..1313] mouse))))
            (VP (VBZ:[1314..1320] arises)
              (PP (IN:[1321..1325] from)
                (NP
                  (NP
                    (NP
                      (QP (IN:[1326..1328] at) (JJS:[1329..1334] least)
                          (CD:[1335..1338] two))
                      (JJ:[1339..1347] distinct) (JJ:[1348..1355] genetic)
                       (NNS:[1356..1364] pathways))
                    (,:[1364..1365] ,)
                    (SBAR
                      (WHNP-2
                        (NP (CD:[1367..1370] one))
                        (WHPP (IN:[1371..1373] of)
                          (WHNP (WDT:[1374..1379] which))))
                      (S
                        (NP-SBJ-2 (-NONE-:[1379..1379] *T*))
                        (VP (VBZ:[1380..1382] is)
                          (ADJP-PRD (JJ:[1383..1392] dependent)
                            (PP (IN:[1393..1395] on)
                              (NP
                                (NP (NNS:[1396..1403] lesions))
                                (PP (IN:[1404..1406] in)
                                  (NP
                                    (NP
                                      (NML-3 (NNS:[1407..1418] chromosomes))
                                      (CD:[1419..1420] 1))
                                    (,:[1420..1421] ,)
                                    (NP
                                      (NML-3 (-NONE-:[1421..1421] *P*))
                                      (CD:[1422..1423] 3))
                                    (,:[1423..1424] ,) (CC:[1425..1428] and)
                                    (NP
                                      (NML-3 (-NONE-:[1428..1428] *P*))
                                      (CD:[1429..1431] 10)))))))))))
                  (,:[1431..1432] ,)
                  (SBAR
                    (WHNP-4
                      (NP (DT:[1433..1436] the) (NN:[1437..1442] other))
                      (WHPP (IN:[1443..1445] of)
                        (WHNP (WDT:[1447..1452] which))))
                    (S
                      (NP-SBJ-4 (-NONE-:[1452..1452] *T*))
                      (VP (VBZ:[1453..1455] is) (RB:[1456..1459] not)
                        (VP (-NONE-:[1459..1459] *?*))))))))))))
    (.:[1459..1460] .)))

;section 11 Span:1464..1509
;PMID: 10811128 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1464..1468] PMID) (::[1468..1469] :) (CD:[1470..1478] 10811128)
        (NN:[1479..1480] -LSB-) (NNP:[1480..1486] PubMed) (::[1487..1488] -)
        (NN:[1489..1496] indexed) (IN:[1497..1500] for)
        (NNP:[1501..1509] MEDLINE-RSB-)))
